Higher Tumor Mutation Burden and Higher PD-L1 Activity Predicts the Efficacy of Immune Checkpoint Inhibitor Treatment in a Patient With Four Lung Cancers. A Case Report

We experienced a patient who had four lung cancers with different pathological features, with the most advanced being diagnosed as pStage IIA. A month after the resection, the original lung cancer had metastasized to the lung and to the liver. Of the original lung cancers that were resected, the big...

Descripción completa

Detalles Bibliográficos
Autores principales: Usuda, Katsuo, Niida, Yo, Iwai, Shun, Funasaki, Aika, Sekimura, Atsushi, Motono, Nozomu, Yamada, Sohsuke, Uramoto, Hidetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280536/
https://www.ncbi.nlm.nih.gov/pubmed/32582526
http://dx.doi.org/10.3389/fonc.2020.00689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280536/
https://www.ncbi.nlm.nih.gov/pubmed/32582526
http://dx.doi.org/10.3389/fonc.2020.00689

Ejemplares similares